Anavex Life Sciences Corp.
AVXL
$9.53
-$0.02-0.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.16M | 115.77M | 120.78M | 132.19M | 138.76M |
| Total Receivables | 820.00K | 666.00K | 2.56M | 2.45M | 1.72M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 448.00K | 702.00K | 711.00K | 931.00K | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 102.43M | 117.14M | 124.04M | 135.57M | 141.54M |
|
|
|||||
| Total Current Assets | 102.43M | 117.14M | 124.04M | 135.57M | 141.54M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 102.43M | 117.14M | 124.04M | 135.57M | 141.54M |
|
|
|||||
| Total Accounts Payable | 6.74M | 7.00M | 4.57M | 9.63M | 3.50M |
| Total Accrued Expenses | 3.93M | 9.56M | 7.73M | 4.84M | 7.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 805.00K | 829.00K | 829.00K | 842.00K | 917.00K |
| Total Other Current Liabilities | 805.00K | 829.00K | 829.00K | 842.00K | 917.00K |
| Total Current Liabilities | 11.47M | 17.38M | 13.13M | 15.30M | 11.75M |
|
|
|||||
| Total Current Liabilities | 11.47M | 17.38M | 13.13M | 15.30M | 11.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.47M | 17.38M | 13.13M | 15.30M | 11.75M |
|
|
|||||
| Common Stock & APIC | 463.58M | 459.14M | 459.10M | 456.33M | 454.32M |
| Retained Earnings | -372.62M | -359.38M | -348.18M | -336.07M | -324.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -89.00K |
| Total Common Equity | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M |
|
|
|||||